The Reserve Bank of India (RBI) last week announced changes to the policy governing external commercial borrowings (ECBs). This represents a reversal on two counts: 1. The all-in-cost ceilings, which were withdrawn about a year ago, have been reintroduced “in view of the improvement in the credit market conditions and prescription drugs narrowing credit spreads in the international markets”

Here is the original post:
Changes to ECB Policy

Hitherto, Indian companies were allowed to make royalty payments to their foreign collaborators under the automatic route within certain limits. These involved payment for technology transfers of a lump sum fee of US$ 2 million and Levitra royalty of 5% on domestic sales and 2% for exports.

Read the original here:
Foreign Collaboration and Royalty Payments

We have discussed the controversy in Indian law surrounding the treatment of bad debts. In short, it has traditionally revolved around two questions. The first pertained to the extent to which commercial reality could influence the determination of taxable income

Visit link:
prescription drugs online and Taxation”>Bad Debts, Commercial Judgment and Taxation

This blog has closely followed the journey of Justice Dinakaran from probable where to buy prescription drugs without prescription elevation to possible impeachment.Regardless of his guilt or innocence, how fair has the system been to him ? In today’s The Indian Express, I have written an opinion piece arguing that Justice Dinakaran has been denied the procedural right to be heard, and this denial is the result of the higher judiciary’s own choice to be insulated from scrutiny.

Read the original here:
Hear Justice Dinarakan out